Paddy Gillespie il 02/04/2025

Cost effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE)-A randomised placebo-controlled clinical trial

Diabet Med. 2025 Apr 2:e70036. doi: 10.1111/dme.70036. Online ahead of print.ABSTRACTAIMS: To investigate the cost-effectiveness of early initiation of metformin and usual care for gestational diabetes mellitus (GDM).METHODS: Economic evaluation from a healthcare perspective, based on the EMERGE ran

Erna Lenters-Westra il 24/03/2025

Managing discordance between HbA1c and glucose management indicator

Diabet Med. 2025 Mar 23:e70023. doi: 10.1111/dme.70023. Online ahead of print.ABSTRACTAIMS: The assessment of haemoglobin A1c (HbA1c) continues to play an essential role in diabetes care; however, major advances in new technologies widen the armament available to clinicians to further refine treatme

Joanne Jordan il 23/03/2025

'The seagull theory: Where people fly in, gather information fly out and nothing ever comes about': A qualitative exploration of barriers and enablers to research participation among adults with type 2 diabetes living in Australian rural communities

Diabet Med. 2025 Mar 23:e70027. doi: 10.1111/dme.70027. Online ahead of print.ABSTRACTAIM: Rural communities are under-represented in diabetes research, with implications for the generalisability, implementation and reach of research outcomes. Increased efforts to conduct diabetes research in, or in

Ashley A Moskovich il 13/03/2025

Correspondence between the Diabetes Eating Problems Survey-Revised and eating disorder diagnosis: Examining the current cut-off for clinically significant eating disorder symptoms

Diabet Med. 2025 Mar 13:e70022. doi: 10.1111/dme.70022. Online ahead of print.ABSTRACTAIMS: Eating disorders (EDs) are associated with severe health complications and early death in individuals with type 1 diabetes, making the accurate detection of EDs crucial so that treatment can be initiated. The

Stéphane Besançon il 04/03/2025

Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial

Diabet Med. 2025 Mar 3:e70007. doi: 10.1111/dme.70007. Online ahead of print.ABSTRACTAIMS: Evidence on outcomes of treating type 1 diabetes (T1D) with long-acting basal insulins in low-resourced settings is lacking. This study aimed to evaluate the impact of switching children and youth with T1D in

Siew Lim il 26/02/2025

Values, principles and research priorities for the implementation of type 2 diabetes prevention after gestational diabetes: A global consensus from Asia, Africa, Americas, Europe and Oceania

Diabet Med. 2025 Feb 26:e70017. doi: 10.1111/dme.70017. Online ahead of print.ABSTRACTAIMS: The implementation of type 2 diabetes prevention after gestational diabetes (GDM) is poor despite research evidence on efficacy. This is limited by the lack of knowledge of the priorities in real-world settin